CCL2 and ischemia: Taken together, these findings suggest that, in addition to ischemia, inflammation is involved in the increase of vascular permeability and disruption of the blood-aqueous barrier via release of inflammatory factors (VEGF, IL-6, MCP-1, and sICAM-1) in BRVO patients with macular edema.